Transformers: Health
On September 20, 2017, The Washington Post brought together doctors, researchers, scientists, medical technology pioneers and business leaders who are pushing boundaries in the health sector and transforming the way we live. They discussed advances in genetics, immunology and technology that are poised to transform human health and make treatments more affordable, accessible -- and ultimately -- more effective.
This live journalism program is part of The Post’s signature series -- Transformers -- which highlights advances that are pushing the boundaries of knowledge, upending industries and transforming everyday life.
On the Cutting Edge: Precision Medicine
Francis Collins, Director of the National Institutes of Health, discusses efforts to accelerate scientific research and innovative advancements in the area of precision medicine.
  • Sep 20
NIH Director Francis Collins talks about the 'All of Us' Research Program, a historic effort to gather data from one million or more people living in the United States.
  • Sep 20
NIH Director Francis Collins discusses the role of his agency in combating the opioid crisis in the United States.
  • Sep 20
Francis Collins, M.D., Ph.D.
Director, National Institutes of Health
Francis S. Collins, M.D., Ph.D. was appointed the 16th Director of the National Institutes of Health (NIH) and sworn in on August 17, 2009. Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the international Human Genome Project. He served as director of the National Human Genome Research Institute at NIH from 1993-2008.
The New Frontier: Technology
A group of doctors, medical experts and entrepreneurs discuss how emerging technologies such as artificial intelligence, wearables, 3D printing, virtual reality and portable tools are being integrated into the health and medical industry and how they will affect prevention and treatment methods in the years to come.
  • Sep 20
The Washington Post’s William Wan asks a group of medical experts, doctors and researchers about the role of regulation in the health and medical field. Dr. James Lu, Co-Founder and Senior Vice President of Applied Genomics at Helix says, “properly done regulation can be a great accelerant for innovation.”
  • Sep 20
Founding Executive Director for Exponential Medicine at Singularity University, Daniel Kraft, says "we live in this amazing age" where medical experts from a variety of fields are working together to address the challenges in healthcare by combining the medical, research, and entrepreneurial sides of medicine.
  • Sep 20
Anthony Atala, M.D.
Director, Wake Forest Institute for Regenerative Medicine
Anthony Atala, MD, is the Director of the Wake Forest Institute for Regenerative Medicine, and the W. Boyce Professor and Chair of Urology at Wake Forest University. Dr. Atala is a practicing surgeon and a researcher in the area of regenerative medicine. His work focuses on growing human cells, tissues and organs.
Daniel Kraft, M.D.
Founding Executive Director and Chair, Exponential Medicine, Singularity University
Daniel Kraft, M.D. has over 20 years of experience in clinical practice, biomedical research and healthcare innovation. Kraft has chaired the Medicine Track for Singularity University since its inception. He is the founder and Executive Director of Exponential Medicine since 2011, a conference that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.
James Lu, M.D., Ph.D.
Co-Founder and Senior Vice President Applied Genomics, Helix
James Lu is a co-founder and SVP of Applied Genomics at Helix, a consumer genomics company that is empowering every person to discover insights into his or her own DNA through an ecosystem of high-quality partners. Prior to Helix, Lu was an Associate in Research at Duke University where he focused on translational genomics and applying machine learning methodologies to electronic medical records.
Girish Putcha, M.D.
Chief Medical Officer, Freenome
Girish Putcha is currently the Chief Medical Officer at Freenome, Director of Laboratory Science for Palmetto GBA’s MolDX program, the founding Medical Director for Orion Genomics, and Managing Director at Personalized Medicine & Diagnostic Solutions. Previously, Girish was the founding Laboratory Director and/Chief Medical Officer at Ariosa Diagnostics, Crescendo Bioscience, Life Technologies, and VitaPath Genetics.
On the Front Lines: The Future of Public Health
Doctors and medical professionals take a look at the latest developments in research, funding and government investment in the fight to combat infectious disease, addiction and other public health issues in the United States and around the world.
  • Sep 20
Former U.S. Surgeon General Regina Benjamin and Dr. Richard Besser, President and CEO of Robert Wood Johnson Foundation, describe what they see as the biggest public health challenges facing the United States.
  • Sep 20
Dr. Richard Besser, President and CEO of Robert Wood Johnson Foundation, says he is concerned that the new GOP health care bill might be “slipping through," adding that he worries about giving too much control to individual states.
  • Sep 20
Regina Benjamin, M.D.
Founder and CEO, BayouClinic, Inc; Former U.S. Surgeon General
Regina Benjamin, M.D. is the Founder and CEO of BayouClinic, Inc. She served as the 18th United States Surgeon General from 2009-2013. Dr. Benjamin specializes in prevention policies and health promotion among individuals as well as large populations, especially concerning obesity, childhood obesity, and children’s health.
Richard E. Besser, M.D.
CEO & President, Robert Wood Johnson Foundation
Richard Besser, M.D., is president and CEO of the Robert Wood Johnson Foundation (RWJF), a position he assumed in April 2017. Besser is the former acting director for the Centers for Disease Control and Prevention (CDC), and ABC News’ former chief health and medical editor.
Sandeep Jauhar, M.D., Ph.D.
Director, Heart Failure Program, Long Island Jewish Medical Center
Sandeep Jauhar, M.D., Ph.D. is a practicing cardiologist and the director of the heart failure program at Long Island Jewish Medical Center. He earned a Ph.D. in experimental physics at U.C. Berkeley before going on to study medicine at Washington University in St Louis. He has been writing regularly about medicine for the Times since 1998.
Transformer: Deepak Chopra
Deepak Chopra, M.D., the world-renowned health and medicine pioneer discusses his career as one of America’s foremost thought leaders on personal transformation and wellness.
  • Sep 20
Deepak Chopra discusses the importance of human contact with nature, saying “we are part of the symphony of the cosmos.”
  • Sep 20
Deepak Chopra, describes some of his six pillars for wellbeing starting with the importance of sleep, stress management, and movement and exercise.
  • Sep 20
Deepak Chopra discusses the connection between human intimacy and spirituality.
  • Sep 20
Deepak Chopra, M.D.
Founder, The Chopra Foundation and Co-Founder, The Chopra Center
World-renowned health and medicine pioneer Deepak Chopra discusses his career as one of America’s foremost thought leaders on personal transformation and wellness.
Frans van Houten (Sponsor Remarks)
In this sponsored segment, Royal Philips CEO Frans van Houten, underlines key priorities the healthcare industry must address in the 21st Century, including breaking down barriers to better care and driving seamless connections in a digitized world where the patient is at the center of care.
  • Sep 20
About Washington Post Live
Washington Post Live is the newsroom’s live journalism platform. Top-level government and business leaders, emerging voices and newsmakers discuss the most pressing national and global issues of the day.
    Presenting Sponsor
      Supporting Sponsor